Recently, we demonstrated an increased LPS localization into liver cells from biopsy proven human and experimental NAFLD, which was significantly associated with liver inflammation through a TLR4 pathway [16]. Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.